New blood biomarkers for the diagnosis of AFP-negative hepatocellular carcinoma
T Wang, KH Zhang - Frontiers in Oncology, 2020 - frontiersin.org
An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is
currently critical for improving the prognosis and reducing the associated economic burden …
currently critical for improving the prognosis and reducing the associated economic burden …
The role of hypoxia inducible factor‐1 in hepatocellular carcinoma
D Luo, Z Wang, J Wu, C Jiang… - BioMed research …, 2014 - Wiley Online Library
Hypoxia is a common feature of many solid tumors, including hepatocellular carcinoma
(HCC). Hypoxia can promote tumor progression and induce radiation and chemotherapy …
(HCC). Hypoxia can promote tumor progression and induce radiation and chemotherapy …
Disruption of PD-1 enhanced the anti-tumor activity of chimeric antigen receptor T cells against hepatocellular carcinoma
X Guo, H Jiang, B Shi, M Zhou, H Zhang… - Frontiers in …, 2018 - frontiersin.org
Cancer immunotherapy has made unprecedented breakthrough in the fields of chimeric
antigen receptor-redirected T (CAR T) cell therapy and immune modulation. Combination of …
antigen receptor-redirected T (CAR T) cell therapy and immune modulation. Combination of …
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches
E Callegari, L Gramantieri, M Domenicali… - Cell Death & …, 2015 - nature.com
MicroRNAs (miRNAs) constitute a large class of short RNAs (eg, 20–24 nucleotides in
length), whose main function is to posttranscriptionally regulate the expression of protein …
length), whose main function is to posttranscriptionally regulate the expression of protein …
MicroRNA profile in HBV-induced infection and hepatocellular carcinoma
G Wang, F Dong, Z Xu, S Sharma, X Hu, D Chen… - BMC cancer, 2017 - Springer
Background MicroRNAs (miRNAs) exhibit essential regulatory functions related to cell
growth, apoptosis, development and differentiation. Dysregulated expression of miRNAs is …
growth, apoptosis, development and differentiation. Dysregulated expression of miRNAs is …
[HTML][HTML] MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1
JJ Yan, YN Zhang, JZ Liao, K Ke, Y Chang, PY Li… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a worldwide malignance and displays marked vascular
abnormalities and active metastasis. MicroRNAs (miRNAs) have been shown to play …
abnormalities and active metastasis. MicroRNAs (miRNAs) have been shown to play …
[HTML][HTML] Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives
L Ma, MS Chua, O Andrisani, S So - World Journal of …, 2014 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC), the predominant form of adult liver malignancies, is a
global health concern. Its dismal prognosis has prompted recent significant advances in the …
global health concern. Its dismal prognosis has prompted recent significant advances in the …
Targeted delivery of microRNA‐199a‐3p using self‐assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice
Hepatocellular carcinoma (HCC) is an aggressive tumor with limited systemic and
locoregional modalities of treatment. Although microRNA (miRNA) based therapies have …
locoregional modalities of treatment. Although microRNA (miRNA) based therapies have …
MicroRNAs involved with hepatocellular carcinoma
B Mao, G Wang - Oncology Reports, 2015 - spandidos-publications.com
Hepatocellular carcinoma (HCC) is one of the most common malignancies, which accounts
for 90% of primary liver cancer. HCC usually presents with poor outcomes due to the high …
for 90% of primary liver cancer. HCC usually presents with poor outcomes due to the high …
Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival
M Liu, J Liu, L Wang, H Wu, C Zhou, H Zhu, N Xu… - PloS one, 2014 - journals.plos.org
Background and Aim Hepatocellular carcinoma (HCC) is one of the most deadly tumors.
Transarterial chemoembolization (TACE) is effective for unresectable HCC. In recent years …
Transarterial chemoembolization (TACE) is effective for unresectable HCC. In recent years …